slight improv area overal in-lin
quarter expect remain modest neutral
maintain neutral rate share follow result
came in-lin street expect miss bullish
forecast top-lin slightli higher expens forecast
hip xfx dental xfx bright spot rel
expect knee xfx continu remain challeng rel
market growth particularli within america xfx importantli
volum gain overal y/i neg q/q
season strong price pressur abat
think volum gain notabl consid overal price
environ seen across larg cap orthoped thu far season
given posit tone aao believ investor expect may
gotten step ahead share like remain rang bound
sign improv busi seen
investor focu remain rosa one central question
zbh improv center whether rosa could meaning
driver revenue management flexibl sell rosa
outright would lift revenue near-term offer
busi model leas implant volum long-term
similar robot model believ earli commerci traction
come avenu would caution investor assum
capit sale outright separ believ key
question around rosa manufactur capac management
continu reiter confid
dental dynam improv sequenti quarter dental
volum improv believ dental market growth remain
rang could room improv given result
even price pressur remain fairli constant rang
rate parti site employe improv
believ posit indic busi head
valuat rate neutral risk discuss
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
zimmer biomet report result overal revenu came
miss btig expect consensu
expect call segment report revenu
knee hip dental
spine cmf compar
btig/consensu estim
organ revenu growth in-lin btig expect
sequenti last quarter gross margin
adjust line btig estim cost associ inventori
initi began fade sg percentag revenu came
versu btig estim call revenu
versu btig estim told adjust ep quarter
btig estim in-lin consensu estim
call
actualsbtig estimate variancetot net bpssg spend bpsr spend bpsadj ebit bpsadj ebitda bpstax bpssourc btig research estim compani filingsvari
made follow chang model
within zbh revenu mix tweak cadenc revenu
better align management commentari around sell day remov
increas equival amount across
revenu categori overal management indic increas overal growth
addit adjust fx impact base today currenc
rate higher impact previous assum still
within management guidanc
 rais gm expect base zbh abil
achiev gain gm manufactur effici currenc swap
convers increas sg base management
commentari increas spend also increas expect share
dilut subsequ quarter base pace stock option exercis
offset out-year gross margin increas slightli tax rate
come slightli base quarterli perform
zimmer biomet rate neutral zimmer biomet trade
estim next twelv month ep project versu comp
group forecast revenu compound-annual-growth-rate
comp group forecast ep compound-annual-growth-rate
also comp group feel discount
overal comp group warrant given zimmer biomet current top-lin
growth expect near-term challeng associ product
qualiti remedi addit invest oper expens
btig publish price target neutral rate stock
risk rate includ follow upsid perspect shorter
organiz turnaround assum less regulatori challeng
assum faster resolut on-go qualiti remedi lack gm
pressur strong uptak robot better expect employe moral
stronger expect price pressur downsid perspect
loss market share addit regulatori requir cost limit
robot adopt longer expect improv compani
btig research estim compani filingsnewold chang
incom etot y/i sale special oper incom incom tax expens net share net incom share gross net net oper tax expens btig research estim compani report
revenu y/i btig research estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
